Effects of interferon-αon gene expression of chemokines and members of the tumour necrosis factor superfamily in HIV-infected patients
- 17 October 2002
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 130 (2) , 279-285
Abstract
We examined the effect of interferon (IFN)-alpha on the expression of 375 genes relevant to inflammatory and immunological reactions in peripheral blood mononuclear cells (PBMC) from HIV-infected patients by cDNA expression array and real-time quantitative RT-PCR. Our main findings were: (i) IFN-alpha induced up-regulation of several genes in the tumour necrosis factor (TNF) superfamily including the ligands APRIL, FasL, TNF-alpha and TRAIL, with particularly enhancing effects on the latter in HIV-infected patients. (ii) While IFN-alpha markedly up-regulated the expression of anti-angionetic ELR- CXC-chemokines (e.g. MIG and IP-10), it suppressed the expression of angiogenic ELR+ CXC-chemokines (e.g. GRO-alpha, IL-8 and ENA-78), with similar patterns in both patients and controls. (iii) IFN-alpha induced a marked increase in gene expression of the HIV co-receptor CCR5 in both patients and controls. We suggest that these effects may contribute to both the therapeutic and toxic effects of IFN-alpha. Moreover, our findings underscore that the biological effects of IFN-alpha in HIV infection are complex and that the clinical net effects of IFN-alpha treatment may be difficult to predict. However, the potent enhancing effect of IFN-alpha on several pro-apoptotic genes in the TNF superfamily and the enhancing effect on CCR5 expression suggest a possible pathogenic role of IFN-alpha in the progression of HIV-related immunodeficiency and suggests caution in the therapeutic use of IFN-alpha in HIV-infected -individuals.Keywords
This publication has 40 references indexed in Scilit:
- Antiviral response by natural killer cells throughTRAIL gene induction by IFN-α/βEuropean Journal of Immunology, 2001
- Induction of a TRAIL mediated suicide program by interferon alpha in primary effusion lymphomaOncogene, 2001
- Early control of HIV replication in primary HIV-1 infection treated with antiretroviral drugs and pegylated IFNα: results from the Primoferon A (ANRS 086) StudyAIDS, 2001
- Induction of Fas Ligand-Mediated Apoptosis by Interferon-αClinical Immunology, 2000
- Inhibition of Angiogenesis and Vascular Tumor Growth by Interferon-Producing CellsThe American Journal of Pathology, 2000
- A Randomized Trial of Interferon alpha Therapy for HIV Type 1 InfectionAIDS Research and Human Retroviruses, 2000
- Safety and antitumor activity of recombinant soluble Apo2 ligandJournal of Clinical Investigation, 1999
- TRAIL/Apo-2-ligand-induced apoptosis in human T cellsEuropean Journal of Immunology, 1998
- Effects of Interferon-α on a Reduced Release of Interleukin-8 from Latently HIV-1-Infected Monocytic Cell Line U937 CellsJournal of Interferon Research, 1994
- Immune-Based Therapeutics: Scientific Rationale and the Promising Approaches to the Treatment of the Human Immunodeficiency Virus-Infected IndividualClinical Infectious Diseases, 1993